Jaguar Health, Inc. (NASDAQ:JAGX) fell 0% during trading on Wednesday . The stock traded as low as $0.15 and last traded at $0.15. 3,634 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 8,223,756 shares. The stock had previously closed at $0.15.
Separately, ValuEngine upgraded Jaguar Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.
The company has a debt-to-equity ratio of 0.52, a current ratio of 1.16 and a quick ratio of 0.11.
Jaguar Health Company Profile
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.